医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

Ph.D

Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors

Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors

バイオテクノロジーヘルスケア臨床試験製薬　 TimeLine: Ochre Bio Appoints Eliot Forster Ph.D

2023年05月17日

Yong Chul Shin, Ph.D., is Chief Scientific Officer of Lysando AG

Yong Chul Shin, Ph.D., is Chief Scientific Officer of Lysando AG

バイオテクノロジーヘルスケア製薬　 TimeLine: Ph.D Yong Chul Shin

2023年04月13日

KBI Biopharma, Inc. and Selexis SA Expand Executive Leadership Team with the Appointment of Abdelaziz Toumi, Ph.D. as Chief Business Officer

KBI Biopharma, Inc. and Selexis SA Expand Executive Leadership Team with the Appointment of Abdelaziz Toumi, Ph.D. as Chief Business Officer

バイオテクノロジーヘルスケアヘルス一般製薬　 TimeLine: and Selexis SA Expand Executive Leadership as Chief Business Officer Inc KBI Biopharma Ph.D

2022年10月31日

HighTide Therapeutics Appoints Jin Chen, Ph.D., as SVP DMPK and Clinical Pharmacology

HighTide Therapeutics Appoints Jin Chen, Ph.D., as SVP DMPK and Clinical Pharmacology

バイオテクノロジーヘルスケアヘルス一般感染症製薬　 TimeLine: as SVP DMPK and Clinical Pharmacology HighTide Therapeutics Appoints Jin Chen Ph.D

2022年01月07日

Overland Pharmaceuticals Appoints Roger Luo, Ph.D. as Chief Development Officer

バイオテクノロジーヘルスケア腫瘍学製薬　 TimeLine: as Chief Development Officer Overland Pharmaceuticals Appoints Roger Luo Ph.D

2021年08月02日

EpimAb Biotherapeutics Appoints Jerry Su, Ph.D. as Chief Technology Officer

EpimAb Biotherapeutics Appoints Jerry Su, Ph.D. as Chief Technology Officer

バイオテクノロジーヘルスケア臨床試験製薬　 TimeLine: as Chief Technology Officer EpimAb Biotherapeutics Appoints Jerry Su Ph.D

2021年05月27日

LianBio Appoints Yizhe Wang, Ph.D., as Chief Executive Officer

LianBio Appoints Yizhe Wang, Ph.D., as Chief Executive Officer

バイオテクノロジーヘルスケア腫瘍学製薬　 TimeLine: as Chief Executive Officer LianBio Appoints Yizhe Wang Ph.D

2021年05月10日

BeiGene Appoints Corsee Sanders, Ph.D. to its Board of Directors

BeiGene Appoints Corsee Sanders, Ph.D. to its Board of Directors

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: BeiGene Appoints Corsee Sanders Ph.D

2020年08月25日

Terns Pharmaceuticals Appoints Senthil Sundaram as Chief Executive Officer, Mark Vignola, Ph.D., as Chief Financial Officer, and Erin Quirk, M.D., as President

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: and Erin Quirk as Chief Financial Officer Mark Vignola Ph.D Terns Pharmaceuticals Appoints Senthil Sundaram as Chief Executive Officer

2020年08月10日

EpimAb Biotherapeutics Appoints David Gu, Ph.D. as New Chief Financial Officer to Drive Corporate Development Plans

EpimAb Biotherapeutics Appoints David Gu, Ph.D. as New Chief Financial Officer to Drive Corporate Development Plans

バイオテクノロジーヘルスケア製薬　 TimeLine: EpimAb Biotherapeutics Appoints David Gu Ph.D

2020年03月24日